Biotechnology Patents
Patents covering antibodies, biologic medicines, and genetic or protein-based therapeutic technologies
Amgen Inc. v. Sanofi
- Jurisdiction: United States (May 18, 2023)
- Original Case: Amgen Inc. v. Sanofi, Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi-Aventis U.S. LLC
- Victims<![CDATA[None]]>Defendants<![CDATA[Sanofi]]><![CDATA[Aventisub LLC]]><![CDATA[Regeneron Pharmaceuticals Inc.]]><![CDATA[Sanofi-Aventis U.S. LLC]]>Plaintiffs<![CDATA[Amgen Inc.]]>Investigators<![CDATA[None]]>Prosecutors<![CDATA[None]]>Defense Attorneys<![CDATA[Paul D. Clement]]>Plaintiff Attorneys<![CDATA[Jeffrey A. Lamken]]>Judges<![CDATA[Neil M. Gorsuch]]><![CDATA[John G. Roberts]]><![CDATA[Clarence Thomas]]><![CDATA[Samuel A. Alito]]><![CDATA[Sonia Sotomayor]]><![CDATA[Elena Kagan]]><![CDATA[Brett M. Kavanaugh]]><![CDATA[Amy Coney Barrett]]><![CDATA[Ketanji Brown Jackson]]>Institutions<![CDATA[United States Supreme Court]]><![CDATA[Amgen Inc.]]><![CDATA[Sanofi]]><![CDATA[Regeneron Pharmaceuticals Inc.]]><![CDATA[United States Court of Appeals for the Federal Circuit]]>
- Case Tags: Patent Law;Enablement Requirement;Biotechnology Patents;Supreme Court Decisions